AR protein disruption by lncRNA-SARCC inhibits the proliferation of VHL-mut RCC cells (not VHL-normal) by suppressing the HIF-2α/c-myc oncogenic pathway [106]. This evidence concerns the gene AR and renal cell carcinoma.